Mayo Clinic doctors published a study claiming that left ventricular assist devices can be used to treat restrictive cardiomyopathy, a heart condition affecting 500,000 Americans. This suggests the market for the blood pumps, which currently stands at about 6,500 implantations per year globally, has room to grow.
Four partners have gotten together in the hopes of developing technology to replace traditional glucometers--and maybe even manage insulin delivery with smartphone-based systems. Wearables specialist Gentag and the Mayo Clinic are expanding upon their ongoing collaboration and adding into the mix a pair of existing partners: sensor maker NovioSense and the Fraunhofer Institute for Microelectronic Circuits and Systems (IMS).
Rochester, MN, home of the Mayo Clinic, is an otherwise unassuming Midwestern city, housing about 111,000 people on the Zumbro River. But the town's leaders have a plan to transform it into a global hub of biotech research and cutting-edge medical technology, approving a $6.5 billion plan that will remake Rochester over the next 20 years.
Baxter, soon to spin out its drug business, is seeding a biotech upstart with the help of the Mayo Clinic, divvying up the labors of R&D in hopes of spurring the discovery of new therapies.
Digital health interventions like telemedicine and text message reminders reduce the relative risk of cardiovascular disease by 40%, concludes a Mayo Clinic meta-analysis of 51 previous studies, affirming the growing use of technology as an adjunct to traditional devices in healthcare.
Drugs like Herceptin have pioneered new--but limited--approaches to HER2-positive cancer that can help about 20% of all breast cancer patients. Now a team of investigators at the Mayo Clinic says they may have found the key to taking this approach one big step forward, with implications for a range of cancers.
In the world of Alzheimer's drug research, there's no lack of certainty among leading researchers. There's just no consensus on what causes the disease or how to treat it.
The Mayo Clinic has found that gadolinium-based contrast agents used in MRI exams leave deposits in the brain. The researchers said that there is no evidence that the gadolinium deposits are harmful to patients and continues to recommend the use of gadolinium-based contrast agents as appropriate.
Investigators have begun testing new drugs that can specifically hunt down and eliminate senescent cells in mice, opening the door to what they say could be a new class of therapeutics that promise to one day slow down the human aging process.
The Mayo Clinic and Gentag are partnering to develop next-generation, wireless, disposable patch sensors to enable researchers to track patient movements in order to better address conditions such as diabetes and obesity.